Showing 181 - 200 results of 80,401 for search '(((( 10 we decrease ) OR ( 50 ((a decrease) OR (nn decrease)) ))) OR ( a step decrease ))', query time: 0.68s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184

    Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

    Published 2020
    “…Right plot show the gradual decrease in the TM tuning for the features highlighted in <b>c</b> as well as the gradual increase in the temporal response profile (i.e. optimal shifts for the prediction of the key BO-NN features using Praat features shown in <b>a</b>). …”
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193

    Results of normal and wide step width (cm). by Fateme Khorramroo (18086501)

    Published 2025
    “…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
  14. 194
  15. 195
  16. 196
  17. 197

    Procedure related data, LBNP, LBPP and hypoxia. by Marcus Thudium (6441863)

    Published 2023
    “…</p><p>Methods</p><p>Five male subjects received continuous hemodynamic, TCD and NIRS monitoring. Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”
  18. 198

    Individual biometric data of patients. by Marcus Thudium (6441863)

    Published 2023
    “…</p><p>Methods</p><p>Five male subjects received continuous hemodynamic, TCD and NIRS monitoring. Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”
  19. 199

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”
  20. 200

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”